7 results
8-K
EX-10.1
NDRA
ENDRA Life Sciences Inc
26 Dec 19
Entry into a Material Definitive Agreement
4:15pm
such Preferred Stock being measured as of the Closing Date).
13.6 Gender and Use of Singular and Plural. All pronouns shall be deemed to refer to the masculine
8-K
EX-10.1
NDRA
ENDRA Life Sciences Inc
11 Dec 19
ENDRA Life Sciences Completes $8.1 Million Private Placement
5:14pm
measured as of the Closing Date).
13.6 Gender and Use of Singular and Plural. All pronouns shall be deemed to refer to the masculine, feminine, neuter
8-K
EX-10.1
NDRA
ENDRA Life Sciences Inc
29 Jul 19
ENDRA Life Sciences Completes Private Placement of $2.8 Million of Convertible Secured Notes and Warrants
8:40am
Document. “Required Buyers” means Buyers holding a majority of the principal amount of the Notes sold pursuant to this Agreement.
-25-
13.6 Gender and Use
8-K
EX-10.3
NDRA
ENDRA Life Sciences Inc
29 Jul 19
ENDRA Life Sciences Completes Private Placement of $2.8 Million of Convertible Secured Notes and Warrants
8:40am
-
(d) The pronouns used herein shall include, when appropriate, either gender and both singular and plural, and the grammatical construction
8-K
EX-10.3
27vo5do 5dtodo8rjbwm
2 Jul 18
ENDRA Life Sciences Completes Private Placement of $1.1 Million of Convertible Secured Notes and Warrants
8:31am
8-K
EX-10.1
e6c1h959p5a6 oasu2
2 Jul 18
ENDRA Life Sciences Completes Private Placement of $1.1 Million of Convertible Secured Notes and Warrants
8:31am
- Prev
- 1
- Next